New advice from the SMC

The Scottish Medicines Consortium has issued its latest set of recommendations on the use of new medicines within NHS Scotland.

SMC accepted linaclotide for restricted use because the balance of costs and benefits meant that it was considered value for  money.
SMC accepted linaclotide for restricted use because the balance of costs and benefits meant that it was considered value for money.
One medicine was approved for restricted use:
  • Linaclotide (Constella), for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation in adults. Its use should be restricted to patients who have not responded adequately to or cannot tolerate all other suitable treatment options.

Two medicines were rejected:

  • Fluocinolone intravitreal implant (Iluvien), for the treatment of vision impairment associated with chronic diabetic macular oedema, considered insufficiently responsive to available therapies.
  • Ivacaftor (Kalydeco), for the treatment of cystic fibrosis in patients aged 6 years and older who have a G551D mutation in the CFTR gene.

Further information: Scottish Medicines Consortium

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New antibiotic prescribing guidance issued for pneumonia

New antibiotic prescribing guidance issued for pneumonia

NICE has published antimicrobial prescribing guidelines...

MIMS summary of NICE COPD guidance updated

MIMS summary of NICE COPD guidance updated

Prescribers can now consult the quick-reference MIMS...

Soft-mist inhaler now available as reusable device

Soft-mist inhaler now available as reusable device

Respimat is now available as a reusable inhaler that...

NICE recommends 'innovative' treatment for type I diabetes

NICE recommends 'innovative' treatment for type I diabetes

Dapagliflozin (Forxiga) has been approved for routine...